Literature DB >> 9572579

Dopamine metabolism in the striatum of hemiparkinsonian model rats with dopaminergic grafts.

T Hashitani1, K Mizukawa, M Kumazaki, H Nishino.   

Abstract

To investigate dopamine (DA) levels as well as DA metabolism by which the striatal DAergic grafts may bring the functional recovery to hemiparkinsonian model rats, a microdialysis study was performed in the striatum, and an autoradiographic analysis for DA transporter was made. In hemiparkinsonian model rats, the concentrations of DA, dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in striatal perfusates, decreased considerably (less than 5%, of control levels). In grafted rats that showed motor recovery, the concentration of DA recovered to almost control level, and DOPAC and HVA to about 20% of controls' suggesting that the rate of DA metabolism is low. L-DOPA loading to grafted rats induced a big release of DOPAC and HVA, thus the DOPAC/DA ratio was close to that of the controls'. Methamphetamine loading increased the concentration of DA but did not change the level of DOPAC and HVA. Haloperidol loading increased DA, DOPAC and HVA. [3H]mazindol binding that reflects the activity of the DA transporter decreased considerably in hemiparkinsonian model rats, but it reappeared more or less in grafted rats. Data indicated that in grafted striatum, the extracellular DA level is almost normal level while the rate of DA metabolism is low. By L-DOPA loading, the grafts show the capacity to synthesize, release and metabolize DA and then the DOPAC/DA ratio is normalized. Responses to methamphetamine and haloperidol, as well as the results of the autoradiographic study suggest that the grafts are under a good feedback regulation of DA metabolism.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9572579     DOI: 10.1016/s0168-0102(97)00109-0

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  3 in total

1.  Vasoactive intestinal peptide (VIP) treatment of Parkinsonian rats increases thalamic gamma-aminobutyric acid (GABA) levels and alters the release of nerve growth factor (NGF) by mast cells.

Authors:  Orhan Tansel Korkmaz; Neşe Tunçel; Muzaffer Tunçel; Elif Mine Oncü; Varol Sahintürk; Mustafa Celik
Journal:  J Mol Neurosci       Date:  2009-12-02       Impact factor: 3.444

2.  PEGylated rhFGF-2 conveys long-term neuroprotection and improves neuronal function in a rat model of Parkinson's disease.

Authors:  Guanghui Zhu; Ganping Chen; Lu Shi; Jenny Feng; Yan Wang; Chaohui Ye; Wenke Feng; Jianlou Niu; Zhifeng Huang
Journal:  Mol Neurobiol       Date:  2014-06-15       Impact factor: 5.590

Review 3.  Electrochemical Detection of Neurotransmitters.

Authors:  Saikat Banerjee; Stephanie McCracken; Md Faruk Hossain; Gymama Slaughter
Journal:  Biosensors (Basel)       Date:  2020-08-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.